Название продукции:4-hydroxy-6-oxo-1H-pyridazine-3-carboxylic acid

IUPAC Name:4-hydroxy-6-oxo-1,6-dihydropyridazine-3-carboxylic acid

CAS:1442437-21-9
Молекулярная формула:C5H4N2O4
Чистота:95%+
Номер в каталоге:CM325395
Молекулярная масса:156.1

Упаковочная единица Доступно для заказа Цена ($) Количество
CM325395-5g in stock NJƀŴ
CM325395-10g in stock țɅȁ
CM325395-25g in stock ŴǧŴ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:1442437-21-9
Молекулярная формула:C5H4N2O4
Точка плавления:-
Smiles-код:O=C(C(C(O)=C1)=NNC1=O)O
Плотность:
Номер в каталоге:CM325395
Молекулярная масса:156.1
Точка кипения:
Номер Mdl:MFCD30489098
Хранение:

Category Infos

Pyridazines
Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.

Column Infos

Deucravacitinib
BMY announced new four-year Sotyktu (deucravacitinib) data demonstrating durable response rates and consistent safety in moderate-to-severe plaque psoriasis. Deucravacitinib is a specific, oral, intracellular TYK2 inhibitor that targets immune responses driven by type 1 IFN and IL-23 that contribute to psoriasis pathogenesis, including IL-17 production and Th1/Th17 polarization.